Transcat (TRNS) Projected to Post Earnings on Tuesday

Transcat (NASDAQ:TRNS) will likely be posting its Q3 2026 results after the market closes on Tuesday, February 3rd. Analysts expect Transcat to post earnings of $0.36 per share and revenue of $80.9850 million for the quarter. Parties are encouraged to explore the company’s upcoming Q3 2026 earning overview page for the latest details on the call scheduled for Tuesday, February 3, 2026 at 4:30 PM ET.

Transcat (NASDAQ:TRNS) last posted its earnings results on Monday, November 3rd. The scientific and technical instruments company reported $0.44 EPS for the quarter, missing the consensus estimate of $0.46 by ($0.02). The business had revenue of $82.27 million for the quarter, compared to analysts’ expectations of $79.51 million. Transcat had a return on equity of 6.81% and a net margin of 3.75%. On average, analysts expect Transcat to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Transcat Price Performance

Shares of NASDAQ TRNS opened at $60.31 on Friday. The company has a quick ratio of 2.06, a current ratio of 2.43 and a debt-to-equity ratio of 0.38. Transcat has a twelve month low of $50.23 and a twelve month high of $97.08. The firm has a market capitalization of $562.69 million, a P/E ratio of 49.43 and a beta of 0.78. The stock’s 50-day simple moving average is $58.90 and its two-hundred day simple moving average is $68.81.

Institutional Trading of Transcat

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Lazard Asset Management LLC bought a new position in shares of Transcat in the second quarter worth about $54,000. Tower Research Capital LLC TRC increased its holdings in Transcat by 245.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,123 shares of the scientific and technical instruments company’s stock worth $97,000 after acquiring an additional 798 shares in the last quarter. Boothbay Fund Management LLC bought a new stake in Transcat during the 3rd quarter worth approximately $368,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Transcat by 6.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock worth $407,000 after purchasing an additional 325 shares during the period. Finally, CIBC Bancorp USA Inc. purchased a new stake in shares of Transcat in the third quarter worth $403,000. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on TRNS. Weiss Ratings restated a “sell (d+)” rating on shares of Transcat in a research note on Monday, December 29th. Northland Securities set a $95.00 target price on Transcat in a research report on Thursday, October 23rd. Finally, Zacks Research upgraded Transcat from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 7th. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $105.33.

About Transcat

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.